Development of vaccines to remove "aging cells" in Japan, and research in the world that accelerates

.

The new vaccine may open the way to treat diseases such as Alzheimer's disease and Parkinson's disease (photo is an image) plyushkin-istock

Japanese research groups have developed vaccines to remove "aging cells" related to aging and many diseases. The paper was released on the 10th in the academic magazine Nature Aging (electronic version). [Video] Is this a desk worker 20 years later? According to the Japan Times, the research group led by Professor Toru Minamino of Juntendo University Graduate School of Medicine. The mouse that has been administered with vaccines has decreased with aging cells accumulated with aging (related to diseases such as arthritis and arteriosclerosis). Minamino said, "It can be expected to be applied to the treatment of diseases related to aging, such as arteriosclerosis and diabetes." Elderly cells are defined as cells that have stopped cell division over time, but they release harmful chemicals and damage normal cells, causing inflammation. The antibodies created by the newly developed vaccine are attached to the aging cells and removed them by leukocytes (with them). The mouse in which the vaccine was vaccinated has slowed the physical function due to aging compared to the unprofessional mouse. The vaccine is also said to have less side effects than existing aging cell removal drugs and lasts longer. Treatment and countermeasures for aging is an area where many experts are studying. Many funds are gathered in developing a method of delaying aging processes and treating aging -related diseases. "There are surprisingly many people who are interested in contribution to longevity (research)." Told. Alcahest, a biotechnology company, which is "a huge amount of money, is gathered," has published several research that administration of young mice blood to old mice will greatly improve brain health. Since then, about 8,000 have been found for aging treatment from protein in the blood. This year, Archaest was acquired by plasma -made manufacturer Grifors for $ 146 million. The two companies have been developing treatments to improve various diseases and symptoms related to aging, such as Alzheimer's disease and Parkinson's disease, and there are six six clinical trials of the second phase. However, some experts think that aging -related diseases are a natural result of rapid human life in about 100 years due to the progress of science and medical care. "From an evolutionary point of view, we haven't been able to live for a long time," said Gerrard Carcenti, Director of the Columbia University Medical Center Genetic Director. "Aging is the invention of mankind. There is no species that has been able to deceive your body, or nature in an animal other than humanity. Elephant may live for 100 years, but the life has changed since 1 million years ago. Not. Humanity broke the back of his body. "

Thomas Kika